in large multicentre trials acarbose up to 600 mg/day for 3 to 12 months improved glycaemic control in approximately 55 % of patients with non-insulin-dependent or insulin-dependent diabetes mellitus .
C0021641
insulin
C0011854
insulin-dependent diabetes mellitus